Vyvgart

Indicated For

generalized myasthenia gravis

About This Medication

# My VYVGART Path Patient Guide: How to Get VYVGART at Low or No Cost ## About This Program My VYVGART Path is a patient support program designed to help eligible patients access VYVGART (efgartigimod alfa-fcab), a prescription medication used to treat generalized myasthenia gravis (gMG) in adults. If you have been prescribed VYVGART and have commercial insurance, this program may help reduce your out-of-pocket costs significantly. ## What Is VYVGART? VYVGART is a neonatal Fc receptor blocker indicated for treating generalized myasthenia gravis in adult patients who are anti-acetylcholine receptor (AChR) antibody positive. The medication is administered as an intravenous infusion over one hour, once weekly for 4 weeks, with subsequent treatment cycles based on clinical evaluation. VYVGART Hytrulo is also available as a subcutaneous injection option for eligible patients. ## Who Qualifies for My VYVGART Path? You may be eligible for My VYVGART Path if you meet the following criteria: - You have a valid prescription for VYVGART or VYVGART Hytrulo from your neurologist - You have insurance coverage through a private or commercial insurance plan - Your prescription is for an FDA-approved indication (generalized myasthenia gravis) - You are not a resident of Massachusetts or Rhode Island (residents of these states are not eligible for the co-pay assistance program) The program does not have specific income thresholds; eligibility is primarily based on having commercial insurance coverage and a valid prescription. ## Financial Assistance Available If you qualify, the VYVGART Co-pay Program offers substantial savings: - **Eligible patients may pay as little as $0** for VYVGART and related administration costs - **Maximum annual benefit: $25,000 per calendar year** for eligible out-of-pocket costs - Assistance covers both the medication and drug administration expenses - Once you reach the $25,000 annual maximum, you are responsible for any remaining out-of-pocket costs for the remainder of that calendar year ## How to Apply ### Step 1: Get Your Prescription Your neurologist will send your VYVGART prescription to a specialty pharmacy that participates in the program. ### Step 2: Contact the Specialty Pharmacy When your specialty pharmacist receives your prescription, they will call you to help you enroll in the VYVGART Co-pay Program. This is typically the easiest enrollment pathway. ### Step 3: Work with an Access Manager You can also contact **My VYVGART Path directly at 1-833-697-2841** to speak with an Access Manager who can: - Help you enroll in My VYVGART Path - Conduct a benefit verification for your specific insurance plan - Confirm your insurance coverage for VYVGART - Answer questions about your eligibility and out-of-pocket costs - Assist with prior authorization requirements if needed ### Step 4: Complete Enrollment Once enrolled, the program will: - Track your reimbursement total throughout the calendar year - Let you know how much of your yearly $25,000 commercial co-pay savings allotment you have remaining - Notify you if you need to submit any claims - Help manage your benefits ## Insurance Requirements You must have **commercial or private insurance coverage** for VYVGART to be eligible for this co-pay assistance program. The program works alongside your existing insurance to reduce your out-of-pocket costs. If VYVGART is not covered by your insurance plan, you may still be eligible for other forms of financial assistance. Contact My VYVGART Path at 1-833-697-2841 to discuss alternative options. ## Prior Authorization Your insurance plan may require prior authorization before approving VYVGART coverage. My VYVGART Path Access Managers can assist with this process. Your healthcare provider will need to submit documentation including: - Your diagnosis and current gMG symptoms - Changes in your MG-ADL (Myasthenia Gravis-Activities of Daily Living) score - Current medications you are taking - Medical records supporting the need for VYVGART ## Timeline and Delivery Once you are enrolled in My VYVGART Path and your prescription is sent to the specialty pharmacy, the specialty pharmacist will coordinate your enrollment and help arrange delivery of your medication. The exact timeline depends on your insurance approval and prior authorization requirements. ## What If Your Application Is Denied? If you are denied coverage or assistance, My VYVGART Path can help: - **Assist with the denial and appeal process** through your insurance company - Work with Field Reimbursement Managers to provide additional clinical support - Explore alternative financial assistance options - Help you understand why the denial occurred and what steps to take next Contact My VYVGART Path at 1-833-697-2841 to discuss your options. ## Important Restrictions - You cannot seek reimbursement from both the VYVGART Co-pay Program and your commercial insurance simultaneously - You cannot use Flexible Spending Accounts (FSAs), Health Savings Accounts (HSAs), or other programs in combination with this co-pay assistance - The program is only available for FDA-approved indications of VYVGART - Residents of Massachusetts and Rhode Island are not eligible ## Additional Support Beyond financial assistance, My VYVGART Path offers: - **Patient-specific benefit verifications** to confirm your out-of-pocket costs - **Referrals to local and national myasthenia gravis resources** and support organizations - **Educational programs** through VYVGART University, which offers free virtual and in-person programs across the US ## Contact Information **My VYVGART Path** Phone: **1-833-697-2841** Access Managers are available to answer questions about enrollment, benefits, insurance coverage, and assistance with denials or appeals. ## Disclaimer This guide provides general information about the My VYVGART Path patient support program. Program details, eligibility requirements, and benefits are subject to change. For the most current and accurate information, contact My VYVGART Path directly at 1-833-697-2841 or speak with your healthcare provider. This guide is not a substitute for professional medical or financial advice.

Program information last verified: March 30, 2026